Literature DB >> 19390306

Current insight on trends, causes, and mechanisms of Hodgkin's lymphoma.

Neil E Caporaso1, Lynn R Goldin, William F Anderson, Ola Landgren.   

Abstract

Hodgkin's lymphoma (HL) has a unique and distinct history, epidemiology, treatment, and biology. A viral agent or infectious agent has long been considered as the etiologic agent and Epstein-Barr virus is the main candidate for the infectious agent causing HL; however, Epstein-Barr virus genome is found within the tumor in only about 20% to 40% of HL cases with a prior diagnosis of infectious mononucleosis. Recently, autoimmune and related conditions have drawn attention to a potential role for immune-related and inflammatory conditions in the etiology and pathogenesis of the malignancy. Evidence from multiply-affected families, a twin study, a case-control study, and population-based registry studies implicate genetic factors. Data from Eastern Asia and among Chinese immigrants in North America indicate increasing incidence trends for HL being associated with westernization. These results emphasize an interaction between environmental and genetic risk factors in HL.

Entities:  

Mesh:

Year:  2009        PMID: 19390306     DOI: 10.1097/PPO.0b013e3181a39585

Source DB:  PubMed          Journal:  Cancer J        ISSN: 1528-9117            Impact factor:   3.360


  8 in total

1.  Hodgkin lymphoma risk following infectious and chronic inflammatory diseases: a large population-based case-control study from Sweden.

Authors:  Sigurdur Y Kristinsson; Ying Gao; Magnus Björkholm; Sigrun Helga Lund; Jan Sjöberg; Neil Caporaso; Lynn R Goldin; Ola Landgren
Journal:  Int J Hematol       Date:  2015-03-11       Impact factor: 2.490

2.  Whole exome sequencing in families at high risk for Hodgkin lymphoma: identification of a predisposing mutation in the KDR gene.

Authors:  Melissa Rotunno; Mary L McMaster; Joseph Boland; Sara Bass; Xijun Zhang; Laurie Burdett; Belynda Hicks; Sarangan Ravichandran; Brian T Luke; Meredith Yeager; Laura Fontaine; Paula L Hyland; Alisa M Goldstein; Stephen J Chanock; Neil E Caporaso; Margaret A Tucker; Lynn R Goldin
Journal:  Haematologica       Date:  2016-06-13       Impact factor: 9.941

Review 3.  Predispositions to Lymphoma: A Practical Review for Genetic Counselors.

Authors:  Morgan Similuk; V Koneti Rao; Jane Churpek; Michael Lenardo
Journal:  J Genet Couns       Date:  2016-06-06       Impact factor: 2.537

4.  Germline mutations in Protection of Telomeres 1 in two families with Hodgkin lymphoma.

Authors:  Mary L McMaster; Chongkui Sun; Maria T Landi; Sharon A Savage; Melissa Rotunno; Xiaohong R Yang; Kristine Jones; Aurélie Vogt; Amy Hutchinson; Bin Zhu; Mingyi Wang; Belynda Hicks; Anand Thirunavukarason; Douglas R Stewart; Stella Koutros; Alisa M Goldstein; Stephen J Chanock; Neil E Caporaso; Margaret A Tucker; Lynn R Goldin; Yie Liu
Journal:  Br J Haematol       Date:  2018-05       Impact factor: 6.998

5.  Hodgkin lymphoma incidence in ethnic enclaves in California.

Authors:  Sally L Glaser; Ellen T Chang; Christina A Clarke; Theresa H M Keegan; Juan Yang; Scarlett Lin Gomez
Journal:  Leuk Lymphoma       Date:  2015-06-18

6.  Neutropenia and Neutropenic Complications in ABVD Chemotherapy for Hodgkin Lymphoma.

Authors:  Bhanu Vakkalanka; Brian K Link
Journal:  Adv Hematol       Date:  2011-05-02

Review 7.  Epidemiological Overview of Hodgkin Lymphoma across the Mediterranean Basin.

Authors:  Massimiliano Salati; Marina Cesaretti; Matteo Macchia; Mufid El Mistiri; Massimo Federico
Journal:  Mediterr J Hematol Infect Dis       Date:  2014-07-01       Impact factor: 2.576

8.  Time Trends in Rates of Hodgkin Lymphoma Histologic Subtypes: True Incidence Changes or Evolving Diagnostic Practice?

Authors:  Sally L Glaser; Christina A Clarke; Theresa H M Keegan; Ellen T Chang; Dennis D Weisenburger
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-07-27       Impact factor: 4.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.